명의 월스트리트 애널리스트에 따르면, Veradigm Inc의 매출 추정치는 $에서 $까지입니다.
Veradigm Inc의 수익 품질 점수는 얼마인가요?
Veradigm Inc의 수익 품질 점수는 B+/49.32682입니다. 이 점수는 수익성, 성장, 현금 창출 및 자본 배분, 레버리지의 네 가지 차원을 기반으로 합니다.
Veradigm Inc는 언제 수익을 보고하나요?
Veradigm Inc의 다음 수익 보고서는 2026-06-14에 발표될 예정입니다.
Veradigm Inc의 예상 수익은 얼마인가요?
월스트리트 애널리스트에 따르면 Veradigm Inc의 예상 수익은 $150.55M입니다.
Veradigm Inc은 수익 기대치를 충족했나요?
Veradigm Inc의 최근 수익은 $로, 기대치를 .
주요 통계
이전 종가
$4.5
시가
$4.15
일일 범위
$4.15 - $4.75
52주 범위
$3 - $6
거래량
1.0K
평균 거래량
203.3K
배당수익률
--
EPS(TTM)
-0.82
시가총액
$500.4M
MDRX란 무엇인가요?
Veradigm, Inc. engages in the provision of clinical, financial, and operational results services. The company is headquartered in Chicago, Illinois and currently employs 2,450 full-time employees. The firm's Veradigm Network provides advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. Its portfolio offers comprehensive solutions that help clients to advance healthcare by providing electronic health records (EHR), financial management, population health management, deidentified data and patient communication solutions. Its Provider business consists of two EHRs, practice management and revenue cycle management, which are patient engagement and enterprise resource planning solutions. Its Payer business delivers end-to-end solutions for health plans, from analytics and data to engagement solutions. Its Life Science Business includes a data and research platform and a commercial media business, which partners with life science and other healthcare companies and their respective brand agencies to deliver media, advertising and education to clinicians.